NVSEF
Price:
$145
Market Cap:
$289.01B
Novartis AG, a global pharmaceutical enterprise established in 1996 and based in Basel, Switzerland, is engaged in the entire lifecycle of healthcare products, from research and development to manufacturing and worldwide commercialization. The company's operations are divided into two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines segment is dedicated to providing advanced prescription medications to both patients and healthcare professionals. Its extensive product portfolio covers a wide range of therapeutic areas, including ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory conditions, cardiovascular health, renal diseases, and metaboli...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2010-04-26
Stock Exchange
OTC
Ticker
NVSEF
According to Novartis AG’s latest financial reports and current stock price. The company's current ROE is 31.54%. This represents a change of 297.35% compared to the average of 7.94% of the last 4 quarters.
The mean historical ROE of Novartis AG over the last ten years is 20.87%. The current 31.54% ROE has changed 51.07% with respect to the historical average. Over the past ten years (40 quarters), NVSEF's ROE was at its highest in in the December 2021 quarter at 24.10%. The ROE was at its lowest in in the December 2016 quarter at 1.28%.
Average
20.87%
Median
18.60%
Minimum
8.97%
Maximum
35.51%
Discovering the peaks and valleys of Novartis AG ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 171.51%
Maximum Annual ROE = 35.51%
Minimum Annual Increase = -66.99%
Minimum Annual ROE = 8.97%
| Year | ROE | Change |
|---|---|---|
| 2025 | 31.78% | 17.22% |
| 2024 | 27.11% | -14.80% |
| 2023 | 31.82% | 171.51% |
| 2022 | 11.72% | -66.99% |
| 2021 | 35.51% | 148.95% |
| 2020 | 14.26% | -32.56% |
| 2019 | 21.15% | 31.84% |
| 2018 | 16.04% | 54.46% |
| 2017 | 10.39% | 15.79% |
| 2016 | 8.97% | -61.14% |
The current ROE of Novartis AG (NVSEF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
30.24%
5-year avg
27.59%
10-year avg
20.87%
Novartis AG’s ROE is less than Roche Holding AG (41.23%), less than Roche Holding AG (41.23%), less than Roche Holding AG (41.23%), less than AstraZeneca PLC (22.41%), less than Novo Nordisk A/S (66.36%), less than Sanofi (14.41%), less than Sartorius Stedim Biotech S.A. (6.60%), less than GSK plc (35.78%), less than Fresenius SE & Co. KGaA (7.76%), less than Chugai Pharmaceutical Co., Ltd. (23.16%),
| Company | ROE | Market cap |
|---|---|---|
| 41.23% | $327.35B | |
| 41.23% | $328.87B | |
| 41.23% | $321.58B | |
| 22.41% | $294.40B | |
| 66.36% | $195.51B | |
| 14.41% | $106.91B | |
| 6.60% | $194.17B | |
| 35.78% | $105.17B | |
| 7.76% | $100.21B | |
| 23.16% | $76.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novartis AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novartis AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novartis AG's ROE?
How is the ROE calculated for Novartis AG (NVSEF)?
What is the highest ROE for Novartis AG (NVSEF)?
What is the 3-year average ROE for Novartis AG (NVSEF)?
What is the 5-year average ROE for Novartis AG (NVSEF)?
How does the current ROE for Novartis AG (NVSEF) compare to its historical average?